James O. Armitage, MD, FACP, FRCP, and Bertrand Coiffier, MD, PhD, on Managing Lymphoma: The French Perspective

2014 ASH Annual Meeting

James O. Armitage, MD, FACP, FRCP, of the University of Nebraska Medical Center, and Bertrand Coiffier, MD, PhD, of the Centre Hospitalier Lyon-Sud discuss three French studies on rituximab maintenance vs wait and watch after R-DHAP in mantle cell lymphoma; R-CHOP with or without radiotherapy in diffuse large B-cell lymphoma; and romidepsin and CHOP in peripheral T-cell lymphoma.

Julie M. Vose, MD, MBA, FASCO, on the AETHERA trial

Keith McCrae, MD, on Splenectomy in Immune Thrombocytopenia

Hagop Kantarjian, MD, on Treating Philadelphia Chromosome–Positive ALL

Incidence of Brain Metastases in Patients Diagnosed With Stage IV NSCLC During the COVID-19 Pandemic

Immunotherapy Doublet as Maintenance Therapy for Extensive-Disease Small Cell Lung Cancer

Acute Myeloid Leukemia World Awareness Day 2021 April 21

Alpelisib Plus Fulvestrant in PIK3CA-Mutant, HR-Positive, HER2-Negative Advanced Breast Cancer After Disease Progression

Effect of Genomic Prostate Score Testing on Choice of Active Surveillance in a Predominantly Black Patient Population

James O. Armitage, MD, FACP, FRCP, and Bertrand Coiffier, MD, PhD, on Managing Lymphoma: The French Perspective

Related Videos

Julie M. Vose, MD, MBA, FASCO, on Nivolumab in Relapsed/Refractory Hodgkin Lymphoma

Keith McCrae, MD, on Managing Heparin-Induced Thrombocytopenia